Balance Sheet Data
Supernus Pharmaceuticals, Inc. (SUPN)
$34.93
-1.06 (-2.95%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 356.02 | 347.07 | 422.53 | 339.68 | 461.33 | 583.51 | 663.81 | 755.16 | 859.08 | 977.31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 102.92 | 87.33 | 140.88 | 148.93 | 165.50 | 189.72 | 215.83 | 245.53 | 279.32 | 317.76 |
| Account Receivables (%) | ||||||||||
| Inventories | 25.66 | 26.63 | 48.33 | 85.96 | 91.54 | 77.25 | 87.88 | 99.98 | 113.74 | 129.39 |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.19 | 10.14 | 6.15 | 9.33 | 96.34 | 31.26 | 35.56 | 40.46 | 46.03 | 52.36 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.84 | -2.74 | -3.45 | -2.04 | -0.41 | -3.01 | -3.42 | -3.89 | -4.43 | -5.04 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.